Evidence map›Paper›PMID 23933660›Full record

ArticleNature communications2013

In vivo time-gated fluorescence imaging with biodegradable luminescent porous silicon nanoparticles.

Luo Gu, David J Hall, Zhengtao Qin, Emily Anglin, Jinmyoung Joo, David J Mooney, Stephen B Howell, Michael J Sailor

Open access · bronzeAbstract read
In one paragraph

Article in Nature communications, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed, 1 pooled it
14.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 1 synthesis or guideline pooled it, 322 citations in OpenAlex.

  1. Systematic Review of Peptide CAQK: Properties, Applications, and Outcomes.International journal of molecular sciences · 2024
    Pooled it
  2. Closing the Loop: High-Precision 3D Photofabrication in Living Tissues.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Modification of Porous Silicon with an Amphiphilic Quaternary Ammonium Hydrocarbon for Nanomedicine Applications.Chemistry of materials : a publication of the American Chemical Society · 2025
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. NonviralACS nano · 2023
    Article
  14. Article
  15. Article
  16. Next-generation biomaterials for dental pulp tissue immunomodulation.Dental materials : official publication of the Academy of Dental Materials · 2023
    Review
  17. Review
  18. Article
  19. Article
  20. Review

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Luo GuDepartment of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California 92093, USA.
David J Hall
Zhengtao Qin
Emily Anglin
Jinmyoung Joo
David J Mooney
Stephen B Howell
Michael J Sailor
University of California, San Diego · USHarvard University · US

Funding

Tumor Therapy/Annihilation Using a Smart NanoPlatform (SNaP)U54CA119335 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ESENER, SADIK · 2005 to 2010
$21.2M
Targeted Smart Nanoplatforms for Multimode ImagingP50CA128346 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI STUPACK, DWAYNE G. · 2008 to 2012
$6.9M
Engineering Multifunctional NanoparticlesR01CA124427 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI BHATIA, SANGEETA N. · 2006 to 2010
$4.7M
Cisplatin Resistance mediated by copper export pathwaysR01CA095298 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HOWELL, STEPHEN B · 2002 to 2014
$3.1M
Chemically amplified response strategies for medical sciences; concepts borrowedDP2OD006499 · OD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ALMUTAIRI, ADAH · 2009 to 2009
$2.3M
Control of the cellular pharmacology of the platinum-containing drugs by CTR1R01CA152185 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HOWELL, STEPHEN B · 2010 to 2014
$1.5M
Biomaterial based breast cancer vaccineR01EB015498 · NIBIB · HARVARD MEDICAL SCHOOL · PI MOONEY, DAVID J · 2013 to 2016
$1.5M
Howard Hughes Medical InstituteHoward Hughes Medical Institute HHMI56005681NCCDPHP CDC HHS 1DP20D006499-01NCI NIH HHS 5-R01-CA124427NCI NIH HHS CA095298NCI NIH HHS CA152185NCI NIH HHS P50 CA128346NCI NIH HHS P50CA128346NCI NIH HHS R01 CA095298NCI NIH HHS R01 CA124427NCI NIH HHS R01 CA152185NCI NIH HHS U54 CA119335NCI NIH HHS U54-CA 119335NIBIB NIH HHS 5R01EB015498NIBIB NIH HHS R01 EB015498NIH HHS DP2 OD006499
6 · The paper itself

Abstract

Fluorescence imaging is one of the most versatile and widely used visualization methods in biomedical research. However, tissue autofluorescence is a major obstacle confounding interpretation of in vivo fluorescence images. The unusually long emission lifetime (5-13 μs) of photoluminescent porous silicon nanoparticles can allow the time-gated imaging of tissues in vivo, completely eliminating shorter-lived (<10 ns) emission signals from organic chromophores or tissue autofluorescence. Here using a conventional animal imaging system not optimized for such long-lived excited states, we demonstrate improvement of signal to background contrast ratio by >50-fold in vitro and by >20-fold in vivo when imaging porous silicon nanoparticles. Time-gated imaging of porous silicon nanoparticles accumulated in a human ovarian cancer xenograft following intravenous injection is demonstrated in a live mouse. The potential for multiplexing of images in the time domain by using separate porous silicon nanoparticles engineered with different excited state lifetimes is discussed.

Indexed as

Ovarian NeoplasmsAnimalsFemaleHumansLuminescent AgentsMiceNanoparticlesNeoplasm TransplantationOptical ImagingSiliconXenograft Model Antitumor AssaysLuminescent AgentsSilicon

Identifiers

PMID23933660
PMCPMC4154512
OpenAlexW2090745907

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.